Literature DB >> 9414383

Expression of cyclin D1, CDK4 and p27KIP1 is associated with the p16MTS1 gene status in human esophageal carcinoma cell lines.

K Kitahara1, W Yasui, H Yokozaki, S Semba, T Hamamoto, T Hisatsugu, E Tahara.   

Abstract

p16MTS1/INK4A negatively regulates cell cycle progression by inhibiting the cyclin D/CDK4 complex that phosphorylates pRb. Frequent homozygous deletions of the p16 gene were recently found in various tumor cell lines. We examined the relationship between the genetic status of p16 and the expression of the cell cycle regulating molecules in human esophageal carcinoma cell lines. Out of eight human esophageal carcinoma cell lines, seven (67.5%) and six (75%) cell lines showed homozygous deletions of the p16 and p15 genes, respectively. All the p16-negative cell lines expressed high levels of cyclin D1, CDK4 and p27KIP1 proteins. Interestingly, the expression level of cyclin D1 was closely correlated to the levels of not only CDK4 but also p27KIP1 protein in p16-negative cell lines. Furthermore, all the p16-negative cell lines expressed Rb protein of approx 110 kDa which corresponds to the phosphorylated form, whereas the cell line with intact p15 and p16 genes did not express pRb. These results suggest that the expression of cyclin D1, CDK4, Rb and p27 is associated with the p16 gene status in esophageal carcinoma cell lines. Alternatively, loss of the p16 gene and subsequent over-expression of cyclin D1 and CDK4 might be involved in autonomous growth of esophageal carcinoma cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9414383

Source DB:  PubMed          Journal:  J Exp Ther Oncol        ISSN: 1359-4117


  6 in total

1.  Over-expression of cyclin D1 regulates Cdk4 protein synthesis.

Authors:  M A Parker; N G Deane; E A Thompson; R H Whitehead; S K Mithani; M K Washington; P K Datta; D A Dixon; R D Beauchamp
Journal:  Cell Prolif       Date:  2003-12       Impact factor: 6.831

2.  Immunohistochemical analysis of p27 (Kip1) in human pituitary glands and in various types of pituitary adenomas.

Authors:  K Komatsubara; S Tahara; K Umeoka; N Sanno; A Teramoto; R Y Osamura
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

3.  Observer variation in the diagnosis of superficial oesophageal adenocarcinoma.

Authors:  A H Ormsby; R E Petras; W H Henricks; T W Rice; L A Rybicki; J E Richter; J R Goldblum
Journal:  Gut       Date:  2002-11       Impact factor: 23.059

4.  Expression of cyclin E in colorectal adenomas and adenocarcinomas: correlation with expression of Ki-67 antigen and p53 protein.

Authors:  W Yasui; H Kuniyasu; H Yokozaki; S Semba; F Shimamoto; E Tahara
Journal:  Virchows Arch       Date:  1996-09       Impact factor: 4.064

5.  Oncogenic transformation of normal enterocytes by overexpression of cyclin D1.

Authors:  Diana Kazanov; Itzhak Shapira; Marjorie Pick; Olga Kolker; Eliezer Liberman; Varda Deutsch; Loudmilla Strier; Hadas Dvory-Sobol; Talya Kunik; Nadir Arber
Journal:  Dig Dis Sci       Date:  2003-07       Impact factor: 3.199

6.  Genetic status and expression of the cyclin-dependent kinase inhibitors in human gastric carcinoma cell lines.

Authors:  Y Akama; W Yasui; H Kuniyasu; H Yokozaki; M Akagi; H Tahara; T Ishikawa; E Tahara
Journal:  Jpn J Cancer Res       Date:  1996-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.